Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $5.34 Million - $6.7 Million
-7,370 Reduced 80.1%
1,831 $1.66 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $175,883 - $235,307
297 Added 3.34%
9,201 $7.16 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $47,267 - $55,721
90 Added 1.02%
8,904 $5.19 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $93,895 - $129,448
216 Added 2.51%
8,814 $4.73 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $31,063 - $36,482
100 Added 1.18%
8,598 $2.95 Million
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $28,162 - $34,999
120 Added 1.43%
8,498 $2.43 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $13,041 - $16,184
58 Added 0.7%
8,378 $2.31 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $42,104 - $51,814
-190 Reduced 2.23%
8,320 $1.92 Million
Q2 2021

Aug 09, 2021

SELL
$180.55 - $233.54 $129,996 - $168,148
-720 Reduced 7.8%
8,510 $1.95 Million
Q4 2020

Jan 29, 2021

SELL
$130.46 - $172.63 $84,799 - $112,209
-650 Reduced 6.58%
9,230 $1.56 Million
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $34,105 - $41,045
250 Added 2.6%
9,880 $1.62 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $14,286 - $17,682
120 Added 1.26%
9,630 $1.34 Million
Q1 2019

Apr 24, 2019

SELL
$111.31 - $131.02 $67,899 - $79,922
-610 Reduced 6.03%
9,510 $1.23 Million
Q3 2018

Oct 22, 2018

SELL
$85.86 - $107.31 $6,010 - $7,511
-70 Reduced 0.69%
10,120 $1.09 Million
Q2 2018

Aug 02, 2018

SELL
$75.7 - $86.88 $16,654 - $19,113
-220 Reduced 2.11%
10,190 $870,000
Q1 2018

May 01, 2018

SELL
$74.21 - $87.6 $19,294 - $22,776
-260 Reduced 2.44%
10,410 $805,000
Q4 2017

Jan 24, 2018

SELL
$81.94 - $87.89 $21,304 - $22,851
-260 Reduced 2.38%
10,670 $901,000
Q3 2017

Oct 25, 2017

BUY
$77.07 - $85.54 $842,375 - $934,952
10,930
10,930 $935,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Duff & Phelps Investment Management CO Portfolio

Follow Duff & Phelps Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Duff & Phelps Investment Management CO with notifications on news.